Wendy Taylor is a seasoned biopharma executive with over 25 years of experience in advancing RNA, small molecule, and biologic therapeutics across multiple therapeutic areas, including oncology, metabolic disease, and ophthalmology. She brings deep expertise in global R&D operations, strategic program leadership, and alliance management.

Ms. Taylor has led major cross-functional initiatives and collaborations with industry leaders such as CSL, Johnson & Johnson, Takeda, and the Cystic Fibrosis Foundation. Previously, she served as Vice President of Operations and Strategic Portfolio Management at Arcturus Therapeutics, where she played a key role in organizational scale-up and managed a $63 million BARDA contract for pandemic vaccine development.

She has held leadership and scientific roles at Regulus Therapeutics, Nitto Denko, and Pfizer, contributing across the drug development lifecycle from discovery through commercialization. 

At SlingstoneBio, she serves on the Board of Directors and provides strategic guidance across development planning, operations, and partnerships.